Indefinite Delivery Contract HHSD200201033744I
Award Date 3/15/10
Last Date to Order 1/31/11
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at a ceiling of $669,123,533.05, is for the provision of various vaccine products and related services to support public health missions across multiple federal agencies. The scope of the IDC includes seasonal and pre-pandemic influenza vaccines,...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $82,229,910.30 contract provides seasonal and pre-pandemic influenza vaccines, as well as other standard immunizations, to support disease prevention and public health preparedness for federal agencies. The IDC is a multiple award vehicle with a ceiling value of $82,229,910.30 and a period of...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The $26.5 million single-award IDC, awarded on March 15, 2010 with a final completion date of February 28, 2011, provides for the delivery of a variety of vaccine products and related services to support the CDC's public health preparedness and...
- This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production. The contract has a ceiling value of $6,338,039,491.48 and a period of performance through December 31, 2030. The primary purpose of this IDC is the development and domestic manufacture of adjuvanted, pandemic influenza vaccines....
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
- The federal contract IDV award was granted to Sanofi Pasteur Inc., a vaccine and pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency. The single-award Indefinite Delivery Contract, valued at up to $9,702,459.30, covers the delivery of various vaccine products and services to support public health preparedness and disease prevention missions of multiple government agencies. This includes seasonal and...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc., the prime contractor. The contract has a total ceiling value of $158,256,000 and a period of performance running through February 28, 2025. The purpose of this IDC is to provide pediatric influenza vaccines to the CDC for the 2024-2025 season. Sanofi Pasteur, as a manufacturer of vaccines and pharmaceutical products, will fulfill task...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), to Sanofi Pasteur Inc., a major global vaccine manufacturer, to procure a wide range of pediatric vaccines. The $1.793 billion multiple-award IDC covers the period from April 1, 2024 to March 31, 2025, with the vaccines intended to support the CDC's Immunization Awardees program and Vaccines for Children (VFC) program. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued up to $54,894,803.20, is for the delivery of adult vaccines over a period ending June 30, 2026. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal agencies. This IDC covers a broad range of vaccine procurement, including...